Histogenics Corp (HSGX) Is Too Cheap To Pass Up For Hedgie Hal Mintz

Sabby Capital actually dumped 68% of its Histogenics Corp (NASDAQ:HSGX) holdings, which is a medicine company, during the third quarter probably when the shares were trading ...

Keep Reading →